和铂医药-B(02142.HK)拟8月27日举行董事会会议批准中期业绩
HBM HOLDINGSHBM HOLDINGS(HK:02142) Ge Long Hui·2025-08-15 09:21

Core Viewpoint - Heptagon Pharmaceuticals-B (02142.HK) has scheduled a board meeting on August 27, 2025, to consider and approve the interim results for the six months ending June 30, 2025, along with other matters [1] Group 1 - The board meeting is set for August 27, 2025 [1] - The meeting will address the interim results for the six months ending June 30, 2025 [1] - Other matters will also be discussed during the board meeting [1]